REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]

DRUG3 trials

Sponsors

Seoul National University Hospital, Romanian Society for Enteral and Parenteral Nutrition

Conditions

Hemodynamic InstabilityHip FractureOrthopedic ProceduresPostoperative Cognitive DysfunctionPostoperative Pain ManagementRecovery

Phase 3

Remimazolam vs. Midazolam for Sedation and Cognitive Outcomes in Orthopedic Surgery

RecruitingNCT07113483

Romanian Society for Enteral and Parenteral NutritionHip Fracture, Orthopedic Procedures, Postoperative Cognitive Dysfunction +1

Start: 2025-10-01End: 2026-02-15Target: 120Updated: 2025-10-01

Unknown Phase

Effect of Remimazolam and Propofol on Hemodynamic Stability During Anesthesia Induction in OPCAB Patients

CompletedNCT05423951

Seoul National University HospitalHemodynamic Instability

Start: 2022-07-26End: 2023-11-08Updated: 2023-11-22

Comparison of Recovery From General Anesthesia in Remimazolam With Flumazenil vs. Propofol

CompletedNCT05435911

Seoul National University HospitalRecovery

Start: 2022-08-02End: 2022-12-21Updated: 2023-01-13

Related Papers

Comparison of recovery profiles between total intravenous anaesthesia with propofol or remimazolam reversed with flumazenil in patients undergoing breast surgery

European Journal of Anaesthesiology2024-01-1119 citations